Forge Nano SPAC Merger Details Revealed: $317M Cash, $1.6B Enterprise Value, $900M Earnout

summarizeSummary

Archimedes Tech SPAC Partners II Co. filed a detailed investor presentation and transcript for its proposed merger with Forge Nano, outlining a $317M cash infusion, a $1.6B combined enterprise value, and a $900M performance earnout.

check_boxKey Events

• Investor Presentation for Forge Nano Merger

  The company furnished the full transcript and presentation from an investor call held on April 28, 2026, detailing the proposed business combination with Forge Nano, Inc.

• Significant Capital Infusion

  The merger is expected to provide approximately $317 million in net cash at closing, significantly bolstering the combined entity's financial position.

• Substantial Combined Valuation

  Forge Nano is valued at $1.2 billion pre-money, with the combined enterprise value projected to be approximately $1.6 billion, reflecting a transformational event for ATII.

• Performance-Based Earnout

  The deal includes a performance earnout of up to $900 million for Forge Nano shareholders, triggered by share price targets ($15, $20, $25) or revenue milestones ($400M, $600M, $800M) over five years.

auto_awesomeAnalysis

This filing provides the full investor presentation and transcript from a conference call detailing the previously announced business combination between Archimedes Tech SPAC Partners II Co. and Forge Nano, Inc. The presentation outlines Forge Nano's atomic-scale technology, its application in semiconductors and lithium-ion batteries, and a three-phase growth plan. Key financial terms include an expected $317 million in net cash at closing, a $1.2 billion pre-money valuation for Forge Nano, and a combined enterprise value of approximately $1.6 billion. The deal also features a performance earnout of up to $900 million tied to share price or revenue targets. This comprehensive disclosure offers critical insights into the combined entity's strategy, financial projections, and the significant capital infusion, providing investors with a detailed understanding of the merger's potential.